Genetics Generation Advancement Corp. (TPEX:4160)
49.90
-0.30 (-0.60%)
At close: Feb 11, 2026
TPEX:4160 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 75.19 | 129 | 128.48 | 57.45 | 85.28 | 68.7 |
Short-Term Investments | 238.19 | 243.15 | 150.32 | 155.76 | 81.73 | 104.79 |
Trading Asset Securities | 31.33 | 40.75 | 35.41 | 44.4 | 31.93 | 35.05 |
Cash & Short-Term Investments | 344.71 | 412.9 | 314.21 | 257.61 | 198.94 | 208.54 |
Cash Growth | -18.77% | 31.41% | 21.97% | 29.49% | -4.61% | -9.78% |
Accounts Receivable | 99.42 | 101.56 | 99.37 | 98.58 | 81.2 | 69.23 |
Other Receivables | 5.77 | 1.46 | 1.72 | 1.74 | 2.52 | 1.67 |
Receivables | 105.18 | 103.02 | 101.09 | 100.32 | 83.72 | 70.9 |
Inventory | 64.09 | 34.98 | 34.8 | 31.29 | 59.71 | 55.33 |
Prepaid Expenses | 11.39 | 7.31 | 4.16 | 6.75 | 14.66 | 9.06 |
Other Current Assets | 1.58 | 1.59 | 2.33 | 3.38 | 2.35 | 2.03 |
Total Current Assets | 526.96 | 559.79 | 456.58 | 399.35 | 359.37 | 345.86 |
Property, Plant & Equipment | 64.88 | 48.74 | 37.45 | 23.77 | 22.83 | 18.57 |
Long-Term Investments | 90.58 | 85.56 | 72.96 | - | - | - |
Goodwill | 10.09 | 10.09 | 10.09 | 10.09 | 10.09 | 10.09 |
Other Intangible Assets | 12.8 | 9.48 | 11.9 | 13.77 | 16.41 | 17.64 |
Long-Term Deferred Tax Assets | 2.25 | 2.15 | 2.28 | 5.09 | 12 | 14.08 |
Other Long-Term Assets | 11.8 | 8.51 | 3.8 | 3.59 | 4.06 | 2.9 |
Total Assets | 719.35 | 724.3 | 595.05 | 455.66 | 424.76 | 409.14 |
Accounts Payable | 39.31 | 43.68 | 43.92 | 41.52 | 38.86 | 35.3 |
Accrued Expenses | 54.74 | 56.1 | 50.05 | 44.71 | 34.25 | 26.28 |
Short-Term Debt | 20 | 30 | 30 | - | - | - |
Current Portion of Leases | 6.33 | 7.97 | 8.11 | 0.76 | 0.46 | 0.05 |
Current Income Taxes Payable | - | 10.84 | 3.12 | - | 1.46 | 1.44 |
Current Unearned Revenue | 11.61 | 10.19 | 8.22 | 9.98 | 21.48 | 23.26 |
Other Current Liabilities | 61.02 | 9.67 | 11.15 | 9.26 | 7.65 | 10.62 |
Total Current Liabilities | 193.01 | 168.43 | 154.56 | 106.22 | 104.15 | 96.95 |
Long-Term Leases | 5.37 | 2.38 | 10.35 | 1.74 | 1.91 | - |
Long-Term Deferred Tax Liabilities | - | - | - | 0.25 | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 0.25 |
Total Liabilities | 198.39 | 170.81 | 164.91 | 108.2 | 106.06 | 97.2 |
Common Stock | 266.9 | 266.9 | 254.05 | 242.47 | 242.47 | 242.47 |
Additional Paid-In Capital | 55.29 | 55.29 | 46.09 | 45.13 | 45.13 | 60.84 |
Retained Earnings | 58.79 | 97.83 | 36.53 | 31.13 | 12.45 | -11.1 |
Comprehensive Income & Other | 139.58 | 133.1 | 93.28 | 28.74 | 18.87 | 20.11 |
Total Common Equity | 520.56 | 553.13 | 429.94 | 347.46 | 318.92 | 312.32 |
Minority Interest | 0.4 | 0.36 | 0.2 | -0 | -0.22 | -0.39 |
Shareholders' Equity | 520.96 | 553.49 | 430.15 | 347.46 | 318.7 | 311.93 |
Total Liabilities & Equity | 719.35 | 724.3 | 595.05 | 455.66 | 424.76 | 409.14 |
Total Debt | 31.7 | 40.35 | 48.46 | 2.49 | 2.37 | 0.05 |
Net Cash (Debt) | 313.01 | 372.56 | 265.75 | 255.12 | 196.57 | 208.5 |
Net Cash Growth | -18.05% | 40.19% | 4.17% | 29.79% | -5.72% | -9.71% |
Net Cash Per Share | 11.69 | 13.89 | 9.91 | 9.50 | 7.35 | 7.81 |
Filing Date Shares Outstanding | 26.96 | 26.69 | 26.69 | 26.69 | 26.69 | 26.69 |
Total Common Shares Outstanding | 26.96 | 26.69 | 26.69 | 26.69 | 26.69 | 26.69 |
Working Capital | 333.94 | 391.36 | 302.02 | 293.13 | 255.22 | 248.91 |
Book Value Per Share | 19.31 | 20.72 | 16.11 | 13.02 | 11.95 | 11.70 |
Tangible Book Value | 497.68 | 533.56 | 407.95 | 323.6 | 292.42 | 284.59 |
Tangible Book Value Per Share | 18.46 | 19.99 | 15.28 | 12.12 | 10.96 | 10.66 |
Machinery | 107.74 | 87.83 | 62.64 | 61.05 | 53.98 | 46.46 |
Leasehold Improvements | 4.97 | 2.52 | 2.14 | 1.48 | 1.48 | 1.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.